The amount of commercial milestone payments under the collaboration agreement.

No definition available.

Name:	elev_CollaborationAgreementCommercialMilestonePayments
Namespace Prefix:	elev_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of development and regulatory milestone payments under the collaboration agreement.

+ References

No definition available.

+ Details

Name:	elev_CollaborationAgreementDevelopmentAndRegulatoryMilestonePayments
Namespace Prefix:	elev_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Term of the collaboration agreement in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	elev_CollaborationAgreementTerm
Namespace Prefix:	elev_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of upfront license fee payable under the collaboration agreement.

+ References

No definition available.

+ Details

Name:	elev_CollaborationAgreementUpfrontLicenseFee
Namespace Prefix:	elev_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount payable as percentage of non royalty sublease income.

+ References

No definition available.

+ Details

Name:	elev_CollaborationAgreementsPaymentsAsPercentageOfNonRoyaltySubleaseIncome
Namespace Prefix:	elev_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The number days of prior written notice to terminate the agreement.

+ References

No definition available.

+ Details

Name:	elev_CollaborationAndLicenseAgreementsNoticePeriod
Namespace Prefix:	elev_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of cash, cash equivalents and marketable securities balances to be maintained as per debt covenant.

+ References

No definition available.

+ Details

Name:	elev_DebtInstrumentCovenantCashCashEquivalentsAndMarketableSecuritiesBalanceToBeMaintained
Namespace Prefix:	elev_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The percent of end of term charge of debt.

+ References

No definition available.

+ Details

Name:	elev_DebtInstrumentEndOfTermChargePercent
Namespace Prefix:	elev_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Period of interest only payments of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	elev_DebtInstrumentInterestOnlyPaymentsTerm
Namespace Prefix:	elev_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The percent of threshold interest rate for calculating effective interest rate.

+ References

No definition available.

+ Details

Name:	elev_DebtInstrumentThresholdInterestRate
Namespace Prefix:	elev_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percent of equity investment from lenders as percent of total amount raised in financing.

+ References

No definition available.

+ Details

Name:	elev_EquityFinancingInvestmentFromLendersAsPercentOfTotalAmountRaisedInFinancing
Namespace Prefix:	elev_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of investments the lenders may invest in future equity financings.

+ References

No definition available.

+ Details

Name:	elev_FutureEquityFinancingInvestmentFromLenders
Namespace Prefix:	elev_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The percentage of Nasdaq beneficial ownership limitations.

+ References

No definition available.

+ Details

Name:	elev_NasdaqBeneficialOwnershipLimitationsPercentage
Namespace Prefix:	elev_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The commission on sale of common stock as percentage of gross proceeds.

+ References

No definition available.

+ Details

Name:	elev_SaleOfCommonStockCommissionAsPercentageOfGrossProceeds
Namespace Prefix:	elev_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of total market capitalization.

+ References

No definition available.

+ Details

Name:	elev_TotalMarketCapitalization
Namespace Prefix:	elev_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586

+ Details

Name:	us-gaap_DebtConversionOriginalDebtAmount1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The price per share of the conversion feature embedded in the debt instrument.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 5
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Name:	us-gaap_DebtInstrumentConvertibleConversionPrice1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Face (par) amount of debt instrument at time of issuance.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69C
-URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

+ Details

Name:	us-gaap_DebtInstrumentFaceAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Contractual interest rate for funds borrowed, under the debt agreement.

+ References

+ Details

Name:	us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=elev_K2HealthventuresLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=elev_TermLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=elev_TermLoanTrancheOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=elev_TermLoanTrancheTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=elev_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=elev_CspcMegalithBiopharmaceuticalCo.LtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=elev_AtMarketOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=elev_CowenAndCompanyLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended
	Jul. 31, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Subsequent Events
Gross proceeds		$ 0	$ 91,977
Common stock, par value		$ 0.0001		$ 0.0001
Subsequent Events \| K2 HealthVentures LLC
Subsequent Events
Number of shares purchased by warrants	339,725
Warrants exercise price	$ 1.3246
Subsequent Events \| K2 HealthVentures LLC \| Term loan
Subsequent Events
Principal amount	$ 50,000
Interest only payments term	30 months
Interest rate (as a percent)	7.95%
Threshold interest rate	3.20%
End of term charge (as a percent)	6.45%
Principal amount for debt conversion	$ 3,250
Common stock, par value	$ 0.0001
Conversion price	$ 2.6493
Nasdaq beneficial ownership limitations, percentage	19.99%
Subsequent Events \| K2 HealthVentures LLC \| Term loan tranche one
Subsequent Events
Principal amount	$ 30,000
Subsequent Events \| K2 HealthVentures LLC \| Term loan tranche two
Subsequent Events
Principal amount	20,000
Subsequent Events \| K2 HealthVentures LLC \| Minimum \| Term loan
Subsequent Events
Cash, cash equivalents and marketable securities balances to be maintained	25,000
Subsequent Events \| K2 HealthVentures LLC \| Maximum
Subsequent Events
Investment from lenders in future equity financings	$ 5,000
Percent of equity investment from lenders	10.00%
Subsequent Events \| K2 HealthVentures LLC \| Maximum \| Term loan
Subsequent Events
Total market capitalization	$ 250,000
Subsequent Events \| License Agreement \| CSPC Megalith Biopharmaceutical Co., Ltd
Subsequent Events
Upfront license fee	$ 27,000
Term of agreement (in years)	10 years
Number of days written prior notice to terminate agreement	180 days
Subsequent Events \| License Agreement \| CSPC Megalith Biopharmaceutical Co., Ltd \| Maximum
Subsequent Events
Development and regulatory milestone payments	$ 148,000
Commercial milestone payments	1,000,000
Payments as percentage of non-royalty sublicense income	50,000
Subsequent Events \| At-The-Market offering \| Cowen and Company, LLC
Subsequent Events
Gross proceeds	$ 50,000
Commission on sale of common stock (as a percent)	3.00%